Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2005 / Cilt: 15 - Sayı: 2

Two siblings with chronic mucocutaneous candidiasis

Kronik mukokütanöz kandidiyazis tanılı iki kardeş

Pages
117–121
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Two siblings, a 12-year-old female, and 6-year-old male diagnosed as familial chronic mucocutaneous candidiasis (Type 3) is presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chronic mucocutaneous candidiasis is a disease characterized by recurrent and therapy resistant candidal infections of skin, nails and mucous membranes.
📊
Key Findings & Data:The most frequent immunologic abnormality is decreased proliferative response of T- lymphocytes to candidal antigen.
💡
Conclusion & Impact:Two siblings, a 12-year-old female, and 6-year-old male diagnosed as familial chronic mucocutaneous candidiasis (Type 3) is presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Tırnaklar · Kandidiyaz · kronik mukokütanöz

Abstract

Chronic mucocutaneous candidiasis is a disease characterized by recurrent and therapy resistant candidal infections of skin, nails and mucous membranes. Chronic candidiasis of mucous membranes and skin is almost always with an immunologic defect. The most frequent immunologic abnormality is decreased proliferative response of T- lymphocytes to candidal antigen. The prognosis of chronic mucocutaneous candidiasis depends on a large scale of the associated disease. The infection can be treated by antifungal drugs and long term remission can be provided by restoration of cellular immunity. Two siblings, a 12-year-old female, and 6-year-old male diagnosed as familial chronic mucocutaneous candidiasis (Type 3) is presented.

Özet

Kronik mukokütanöz kandidiyazis, deri, tırnak ve muköz membranlarm tedaviye dirençli tekrarlayan kandida infeksiyonudur. Mukoza ve deride kronik kandidiyazis hemen daima immünolojik defekt ile ilişkilidir. En sık görülen immünolojik bozukluk T-lenfositlerin kandida antijenine karşı prolijeratif yamtındaki azalmadır. Prognoz büyük ölçüde kandidiyazise eşlik eden hastalığa bağlıdır. Antifungal ilaçlar ile in/efcsiyonun tedavisi yapılabilmekte ve sellüler immunitenin restorasyonu ile uzun süreli remisyonu sağlanabilmektedir. Bir yaşından beri el ve ayak tırnaklarında kandida infeksiyonu bulunan ve aldığı çeşitli tedavilerden fayda görmeyen 12 yaşındaki kız olgu ile benzer yakınmaları bulunan 6 yaşındaki erkek kardeş ailevi kronik mukokütanöz kandidiyaziz (Tip-3) tanısı ile sunulmuştur.

🔖

Cite This Article

HIZARCIOĞLU, M., APA, H., KAYSERİLİ, E., GÜLEZ, P., ERGÜDENLER, Y. (2005). Two siblings with chronic mucocutaneous candidiasis. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 15 - Sayı: 2, 117–121. https://ajindex.com/articles/268551

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. De Moraes-Vasconcelos D, Orli NM, Romano CC, Iqueoka RY, Duarte AJ. Characterization of the cellular immune function of patients with chronic mucocutaneous candidiasis. Clin Exp Immunol 2001; 123:247-53
  2. Kirkpatrick CH. Cronic mucocutaneous candidiasis. Pediatr infect Dis J 2001;20:197-206
  3. Kirkpatrick CH. Cronic mucocutaneous candidiasis. J Am Acad Dermatol 1994;31(3 Pt 2):s.14-7
  4. RJ Hay, SOB Roberts. Chronic mucocutaneous candidiasis. In: RH Champion, JL Burton, FJG Ebling,eds. Textbook of Dermatology Massachusetts: Black-well,1992:1191-93
  5. Lilic D. New perspectives on the immunology of chronic mucocutaneous candidiasis.Curr Opin Infect Dis 2002;15:143-7
  6. Palma-Carlos AG, Palma-Carlos ML. Chronic mucocutaneous candidiasis revisited. Allerg Immunol (Paris2001;33:229-32
  7. Rybojad M, ağabeymelec P, Feuilhade M, Morel P, Bourrat E. Familial chronic mucocutaneous candi-diasis associated with autoimmune polyendocrino-pathy. Treatment with fluconazole: 3 cases. Ann Dermatol Venereol 1999; 126: 54-6
  8. Williamson MM, Gordon RD. Severe chronic mucocutaneous candidiasis. Favourable response to oral therapy with ketoconazole. Med J Aust 1983;276-8
  9. Horsburgh CR Jr, Kirkpatrick CH. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. Am J Med 1983;74(1B):23-9
  10. Polizzi B, Origgi L, Zuccaro G, Matti P, Scorza R. Case report: successful treatment with cimetidine and zinc sulphate in chronic mucocutaneous candidiasis. Am J Med Sci 1996; 311: 189-90
  11. Masi M, De Vinci C, Baricordi OR. Transfer factor in chronic mucocutaneous candidiasis. Biotherapy 1996; 97-103.